Validation of synthetic M-protein materials for external quality assessment: homogeneity, commutability, and stability
Open Access
- 3 September 2026
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract
Objectives: Accurate quantification of M-proteins is important for clinical management of monoclonal gammopathies. Reliable assessment of trueness on M-protein quantification in External Quality Assessment (EQA) schemes is difficult due to the lack of reference methods and materials for target value assignment. We propose a strategy to produce targeted synthetic M-protein EQA materials by spiking known amounts of human(ised) therapeutic monoclonal antibodies (t-mAb) into null serum. This paper validates homogeneity, commutability, and stability of these materials. Methods: Homogeneity was assessed on two aliquoted synthetic M-protein EQA materials comparing within-vial variation with between-vial variation for sodium, total protein, IgG and M-protein quantification. Commutability was assessed by comparing between-method differences in 51 patient-derived and nine synthetic M-protein EQA materials among various M-protein quantification methods. Stability was checked by reanalysis of two previously distributed synthetic M-protein EQA materials. Results: Within- and between-vial variation were similar in both samples, and therefore homogeneity criteria were met. Commutability was observed for eight out of nine samples, whereas one hypergammaglobulinemic sample was non-commutable. Long-term storage stability at −80 °C was found acceptable in both samples. Conclusions: Due to their proven homogeneity, commutability, and stability, targeted synthetic M-protein EQA materials are suitable for use in M-protein EQA schemes. This allows for the assessment of laboratory performances based on target values, and opens the way for harmonisation and exchangeability of M-protein diagnostic methods. Additionally, it provides a new source for the production of M-protein EQA materials, alleviating the demand for large volumes of patient material needed to organise M-protein EQA schemes.Keywords
This publication has 18 references indexed in Scilit:
- Advances in multiple myeloma blood-based monitoring and its clinical applicationsCritical Reviews in Clinical Laboratory Sciences, 2025
- A review of clinical guidelines, laboratory recommendations and external quality assurance programs for monoclonal gammopathy testingCritical Reviews in Clinical Laboratory Sciences, 2023
- Recommendations for Setting a Criterion and Assessing Commutability of Sample Materials Used in External Quality Assessment/Proficiency Testing SchemesClinical Chemistry, 2023
- To skim or splice? Comparing the quantification of M-proteins using two peak-integration protocols across multiple electrophoresis platformsClinical Biochemistry, 2022
- An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresisClinical Chemistry and Laboratory Medicine (CCLM), 2019
- Recognition and management of common, rare, and novel serum protein electrophoresis and immunofixation interferencesClinical Biochemistry, 2018
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaThe Lancet Oncology, 2016
- Challenges of measuring monoclonal proteins in serumClinical Chemistry and Laboratory Medicine (CCLM), 2016
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working GroupBritish Journal of Haematology, 2003